The power of linked open data — exploiting ligand-transporter interaction profiles

webinar

Tue, 24 May 2016, 16:00 CEST (Berlin)

Prof. Dr. Gerhard F. Ecker

The power of linked open data — exploiting ligand-transporter interaction profiles

With the public availability of large integrated data sources such as the Open PHACTS Discovery Platform, retrieval of data sets for certain protein targets of interest measured under consistent assay conditions is no longer a time consuming process. Especially the use of workflow engines such as KNIME or Pipeline Pilot allows to submit complex queries and enables to simultaneously search for several targets. Data can then directly be used as input to e.g. ChemBioNavigator or SeeSAR for ligand- and structure-based studies. Within this webinar we will present case studies for the development of ligand-transporter interaction models and their use for selectivity profiling.

Current news

category
Events
Recordings of the BioSolveIT Day 2025 Available
October 15, 2025 13:39 CEST
Missed BioSolveIT Day 2025? The recordings from BioSolveIT Day 2025 are now live! Packed with practical insights for medicinal and computational chemists, the sessions showcase how SeeSAR, infiniSee, Chemical Space Docking®, and CoLibri accelerate real-world discovery, from pocket-aware design and HYDE-guided decisions to trillion-scale, synthesizable chemical space exploration and in-house...
Read on
Enamine’s REAL Space September 2025 Update - Now 83 Billion!
September 23, 2025 10:31 CEST
The September 2025 update of Enamine’s REAL Space brings a new expansion, now featuring over 83 billion accessible, drug-like products, up from 76 billion in the previous release. Built from 172 curated reactions and 192,487 reagents and building blocks based on in-house knowledge, this version further enhances one of the...
Read on
WuXi’s GalaXi Space September 2025 – Expanded to 26 Billion Molecules!
September 17, 2025 10:03 CEST
The September 2025 update of WuXi LabNetwork’s GalaXi Space delivers a major expansion, now featuring over 25.8 billion synthesis-ready products. Built from 185 curated reactions and 30,877 high-quality building blocks, GalaXi is one of the largest tangible Chemical Spaces for modern drug discovery. This release broadens structural diversity with novel...
Read on